Editorial Commentary
Epidermal growth factor receptor exon 20 insertion mutations: are we getting closer to solving the puzzle?
Translational Lung Cancer Research
2024;
13
(11)
:2864-2867
.
(30 November 2024)
Original Article
Lung autotransplantation for advanced central lung cancer after neoadjuvant immuno-chemotherapy: a case series study
Translational Lung Cancer Research
2024;
13
(11)
:2868-2879
.
(30 November 2024)
The potential high-risk population for lung cancer screening: determination of initial screening age and heterogeneity in histology and sex
Translational Lung Cancer Research
2024;
13
(11)
:2880-2889
.
(30 November 2024)
Comparing the outcomes of MR-based versus CT-based tumor delineation in locally advanced non-small cell lung cancer treated with hypo-fractionated radiotherapy and concurrent chemotherapy
Translational Lung Cancer Research
2024;
13
(11)
:2890-2902
.
(30 November 2024)
Altered carnitine transporter genes (SLC22A5, SLC22A16, SLC6A14) expression pattern among lung cancer patients
Translational Lung Cancer Research
2024;
13
(11)
:2903-2917
.
(30 November 2024)
Treatment of metastatic ALK-positive non-small cell lung cancer: real-world outcomes in a single center study
Translational Lung Cancer Research
2024;
13
(11)
:2918-2933
.
(30 November 2024)
Optimizing epidermal growth factor receptor-tyrosine kinase inhibitor treatment in lung cancer: a systematic review and meta-analysis of the influence of gastric acid suppressants
Translational Lung Cancer Research
2024;
13
(11)
:2934-2946
.
(30 November 2024)
Three-dimensional reconstruction for determining positional indications of pulmonary segmentectomy/subsegmentectomy for ground glass opacity-dominant clinical T1a-bN0 non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(11)
:2947-2957
.
(30 November 2024)
Construction and validation of deep learning model for cachexia in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors: a multicenter study
Translational Lung Cancer Research
2024;
13
(11)
:2958-2971
.
(30 November 2024)
Predictive value of longitudinal systemic inflammatory markers for pathologic response to neoadjuvant PD-1 blockade in resectable non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(11)
:2972-2986
.
(30 November 2024)
Characterization of the BH1406 non-small cell lung cancer (NSCLC) cell line carrying an activating SOS1 mutation
Translational Lung Cancer Research
2024;
13
(11)
:2987-2997
.
(30 November 2024)
Phase Ib/II study of imprime PGG and pembrolizumab in patients with previously treated advanced non-small cell lung cancer (NSCLC): BTCRC LUN 15-017
Translational Lung Cancer Research
2024;
13
(11)
:2998-3009
.
(30 November 2024)
STING facilitates the development of radiation-induced lung injury via regulating the PERK/eIF2α pathway
Translational Lung Cancer Research
2024;
13
(11)
:3010-3025
.
(30 November 2024)
Mutational differences between primary cancer tissue and circulating tumor cells in early-stage non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(11)
:3026-3038
.
(30 November 2024)
Analysis of the lymph node metastasis distribution in patients with invasive resectable non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(11)
:3039-3049
.
(30 November 2024)
Treatment patterns and clinical outcomes of resectable central non-small cell lung cancer patients undergoing sleeve lobectomy: a large-scale, single-center, real-world study
Translational Lung Cancer Research
2024;
13
(11)
:3050-3066
.
(30 November 2024)
EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer
Translational Lung Cancer Research
2024;
13
(11)
:3067-3082
.
(30 November 2024)
Evaluation of the ASPYRE-Lung targeted variant panel: a rapid, low-input solution for non-small cell lung cancer biomarker testing and experience from three independent sites
Translational Lung Cancer Research
2024;
13
(11)
:3083-3095
.
(30 November 2024)
Prognostic impact of targetable driver alterations in resected early-stage lung cancer
Translational Lung Cancer Research
2024;
13
(11)
:3096-3105
.
(30 November 2024)
Association of baseline plasma D-dimer and platelets with progression-free survival in patients with stage IV non-small cell lung cancer treated with anti-PD-1 antibody
Translational Lung Cancer Research
2024;
13
(11)
:3106-3121
.
(30 November 2024)
Circulating tumor cells are associated with lung cancer subtypes: a large-scale retrospective study
Translational Lung Cancer Research
2024;
13
(11)
:3122-3138
.
(30 November 2024)
Construction of a risk prediction model for isolated pulmonary nodules 5–15 mm in diameter
Translational Lung Cancer Research
2024;
13
(11)
:3139-3151
.
(30 November 2024)
Construction and validation of a prognostic model based on oxidative stress-related genes in non-small cell lung cancer (NSCLC): predicting patient outcomes and therapy responses
Translational Lung Cancer Research
2024;
13
(11)
:3152-3174
.
(30 November 2024)
Fluorofenidone enhances cisplatin efficacy in non-small cell lung cancer: a novel approach to inhibiting cancer progression
Translational Lung Cancer Research
2024;
13
(11)
:3175-3188
.
(30 November 2024)
Lower respiratory tract microbiome is associated with checkpoint inhibitor pneumonitis in lung cancer patients
Translational Lung Cancer Research
2024;
13
(11)
:3189-3201
.
(30 November 2024)
Correlations between 14-gene RNA-level assay and clinical and molecular features in resectable non-squamous non-small cell lung cancer: a cross-sectional study
Translational Lung Cancer Research
2024;
13
(11)
:3202-3213
.
(30 November 2024)
Influence of pleural invasion on survival in pathologic T3–4N0M0 non-small cell lung cancer: a propensity score matching study based on the Surveillance, Epidemiology, and End Results database
Translational Lung Cancer Research
2024;
13
(11)
:3214-3223
.
(30 November 2024)
Review Article
EGFR exon 20 insertion mutation and MET exon 14 skipping mutation in non-small cell lung cancer: a scoping review in the Chinese population
Translational Lung Cancer Research
2024;
13
(11)
:3224-3240
.
(30 November 2024)
The latest advances in liquid biopsy for lung cancer—a narrative review
Translational Lung Cancer Research
2024;
13
(11)
:3241-3251
.
(30 November 2024)
Case Report
Invasive mucinous adenocarcinoma harbored MET exon 14 skipping mutation: case report
Translational Lung Cancer Research
2024;
13
(11)
:3252-3255
.
(30 November 2024)
